Application progress of 68Ga-FAPI PET in gastric and colorectal cancer
10.3760/cma.j.cn321828-20240422-00140
- VernacularTitle:68Ga-FAPI PET在胃癌及结直肠癌中的应用进展
- Author:
Yiru FU
1
;
Chunxia QIN
1
;
Xiaoli LAN
1
Author Information
1. 华中科技大学同济医学院附属协和医院核医学科、分子影像湖北省重点实验室，武汉 430022
- Publication Type:Journal Article
- Keywords:
Stomach neoplasms;
Colorectal neoplasms;
Quinolines;
Gallium radioisotopes;
Positron-emission tomography;
Trends
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2025;45(5):308-312
- CountryChina
- Language:Chinese
-
Abstract:
In recent years, fibroblast activation protein inhibitor (FAPI) PET imaging, which targets the tumor microenvironment, has shown significant potential in evaluating solid tumors. Particularly, studies have demonstrated the value of 68Ga-FAPI PET in evaluation of gastric and colorectal cancer. This article reviews previous studies and provides an overview of how 68Ga-FAPI PET can be used in the diagnosis, staging, recurrence monitoring, clinical management, efficacy evaluation, and prognostic prediction of gastric and colorectal cancer, in order to provide a basis for the further utilization of this novel imaging agent, 68Ga-FAPI, in gastric and colorectal cancer.
